BRAINTREE, Mass., April 14, 2026 /PRNewswire/ -- MIB, the life insurance industry's most trusted and secure partner for data-driven insights...
The natural, functional mushroom market is experiencing rapid growth, projected to exceed USD 60 billion by 2030, driven by rising...
FDA assigned PDUFA target action date of January 29, 2027 No advisory committee meeting expected BOSTON, April 14, 2026 (GLOBE...
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesine Convergence of impaired autophagy and synaptic...
TORONTO and HOUSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage...
BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead...
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces...
Siemens Healthineers joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementiasWASHINGTON, April 09,...
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions HACKENSACK, NJ...
Clinical studies link modern stress to measurable changes in brain architecture, fueling a new movement toward "brain fitness."NEW BERN, N.C.,...
The Miami-based diagnostics company launches publicly with exclusive partnerships with Kennel Connection and Pawp, bringing clinical-grade pet health intelligence to...
As dementia cases rise globally, more physicians and researchers are pointing to early intervention to improve patient outcomesPublished in the...
North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in...
As brain–computer interfaces advance, neural data emerges as a key asset.NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience...
As brain–computer interfaces advance, neural data emerges as a key asset.NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience...
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to...
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from...
BOSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity,...
Access the Moleculin CEO Corner here HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or...
New investor Sectoral Asset Management joins growth financing round to support acceleration of commercial growthWEST JORDAN, Utah, April 07, 2026...